Cannabinoids in Autism Spectrum Disorder Treatment: Safety and Effectiveness Evidence
Clinical Takeaway Research suggests that CBD-based treatments, particularly combined CBD and THC formulations, may reduce
Clinical Takeaway Research suggests that CBD-based treatments, particularly combined CBD and THC formulations, may reduce
Clinical Takeaway GLP-1 receptor agonists, commonly known as medications like semaglutide, were studied using genetic
Clinical Takeaway In a randomized, double-blind, placebo-controlled crossover trial of 29 autistic children aged 5
Clinical Takeaway Tailored cannabis prevention messaging that first addresses and rebukes a teen’s negative reaction
Clinical Takeaway A digital therapeutic tailored specifically for people living with HIV showed feasibility and
Clinical Takeaway CBD can interact with other medications, particularly opioids and drugs processed by the
Clinical Takeaway A smartphone-based AI relational agent (Woebot for Substance Use Disorders) was tested in
Clinical Takeaway Children born to mothers who used cannabis during pregnancy showed a modest increase
Clinical Takeaway Cannabinoid-based treatments, including CBD-rich preparations, have shown promising early results for reducing certain
Clinical Takeaway Adolescents with depression and anxiety symptoms showed increased likelihood of initiating and using